↓ Skip to main content

Dove Medical Press

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, May 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users
facebook
2 Facebook pages

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
67 Mendeley
Title
Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, May 2012
DOI 10.2147/dmso.s23261
Pubmed ID
Authors

Mohamed A AlMaatouq

Abstract

More than 50 million Muslims throughout the world with type 2 diabetes mellitus (T2DM) fast for one lunar month (Ramadan) each year. Health care providers within and outside the Muslim world need to be aware of the nature of these partial days of fasting and their risks (and potential benefits) to people with T2DM, and need to provide Ramadan-adjusted diabetes care. Hypoglycemia during the fasting days represents the greatest health risk for these patients; hence, diabetes-related pharmacotherapy needs to be tailored and adjusted with this risk in mind. With limited trial data available, this review proposes practical modifications to the usual pre-Ramadan antidiabetic regimens that are based on pathophysiological principles, clinical trial evidence (where available), expert opinion, and extended practical experience. Individualization of care is paramount in this regard to take into consideration the patient and societal, cultural, and economic variables.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
India 1 1%
Saudi Arabia 1 1%
Unknown 64 96%

Demographic breakdown

Readers by professional status Count As %
Unspecified 11 16%
Student > Master 8 12%
Student > Bachelor 8 12%
Other 7 10%
Researcher 6 9%
Other 15 22%
Unknown 12 18%
Readers by discipline Count As %
Medicine and Dentistry 28 42%
Unspecified 11 16%
Nursing and Health Professions 7 10%
Social Sciences 4 6%
Computer Science 1 1%
Other 3 4%
Unknown 13 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2015.
All research outputs
#8,618,954
of 25,584,565 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#350
of 1,182 outputs
Outputs of similar age
#59,644
of 176,069 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#2
of 4 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,182 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,069 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.